Suppr超能文献

[眼科制剂Polyspectran(新霉素、多粘菌素B和杆菌肽/短杆菌肽的组合)和土霉素(土霉素与多粘菌素B)错误地不再予以报销]

[Ophthalmic preparations Polyspectran (combination of neomycin, polymyxin B and bacitracin/gramicidin) and Terramycin (oxytetracycline with polymyxin B) mistakenly no longer reimbursed].

作者信息

Brandenburg H C, van Dissel J T, Swart W

机构信息

Afd. Klinische Farmacie en Toxicologie, Academisch Ziekenhuis, Leiden.

出版信息

Ned Tijdschr Geneeskd. 1997 Jan 25;141(4):204-5.

PMID:9064530
Abstract

The Netherlands' Ministry of Health and the health insurance companies have drawn up a list of preparations which will no longer be reimbursed. The ocular antibiotic preparations Polyspectran and Terramycin are on the list. However, there are no satisfactory alternative with respect to the broadness of the antibiotic spectrum required. In addition, some alternatives have serious side effects or may induce bacterial resistance.

摘要

荷兰卫生部和健康保险公司已经拟定了一份不再予以报销的制剂清单。眼部抗生素制剂Polyspectran和土霉素在这份清单上。然而,就所需抗生素谱的广度而言,没有令人满意的替代药物。此外,一些替代药物有严重的副作用或可能会诱发细菌耐药性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验